Molina Healthcare, Inc. (NYSE:MOH) Receives $350.92 Average PT from Analysts

Molina Healthcare, Inc. (NYSE:MOH) has been assigned an average rating of “Hold” from the eleven brokerages that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $351.31.

MOH has been the topic of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $359.00 price objective on shares of Molina Healthcare in a report on Thursday. StockNews.com cut Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Friday, August 25th. Bank of America increased their price objective on Molina Healthcare from $340.00 to $350.00 in a report on Thursday, July 27th. UBS Group began coverage on Molina Healthcare in a report on Tuesday, June 20th. They issued a “neutral” rating and a $310.00 price target on the stock. Finally, JPMorgan Chase & Co. lowered their price target on Molina Healthcare from $348.00 to $341.00 in a report on Friday, July 7th.

Molina Healthcare Stock Down 0.4 %

Shares of NYSE MOH opened at $326.97 on Friday. Molina Healthcare has a one year low of $256.19 and a one year high of $374.00. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.52 and a quick ratio of 1.52. The business’s fifty day moving average price is $311.72 and its 200-day moving average price is $292.80. The stock has a market capitalization of $19.06 billion, a PE ratio of 20.72, a P/E/G ratio of 1.08 and a beta of 0.65.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, July 26th. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.05 by $0.60. The business had revenue of $8.33 billion for the quarter, compared to analysts’ expectations of $8.32 billion. Molina Healthcare had a return on equity of 35.87% and a net margin of 2.81%. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.55 EPS. On average, equities research analysts anticipate that Molina Healthcare will post 20.78 EPS for the current year.

Insider Activity

In other news, CAO Maurice Hebert sold 692 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $328.15, for a total transaction of $227,079.80. Following the transaction, the chief accounting officer now directly owns 8,528 shares in the company, valued at approximately $2,798,463.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Maurice Hebert sold 692 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $328.15, for a total transaction of $227,079.80. Following the transaction, the chief accounting officer now directly owns 8,528 shares in the company, valued at approximately $2,798,463.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Barbara L. Brasier sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $303.89, for a total value of $455,835.00. Following the transaction, the director now owns 3,232 shares in the company, valued at $982,172.48. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,938 shares of company stock worth $5,474,336. 1.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Molina Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in shares of Molina Healthcare by 18.4% in the 1st quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company’s stock worth $2,151,448,000 after buying an additional 1,001,372 shares during the last quarter. BlackRock Inc. grew its position in shares of Molina Healthcare by 2.4% in the 2nd quarter. BlackRock Inc. now owns 4,865,464 shares of the company’s stock worth $1,465,672,000 after buying an additional 113,511 shares during the last quarter. Capital World Investors grew its position in shares of Molina Healthcare by 1.2% in the 2nd quarter. Capital World Investors now owns 4,352,122 shares of the company’s stock worth $1,311,033,000 after buying an additional 53,139 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Molina Healthcare by 59.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,787,368 shares of the company’s stock worth $1,013,084,000 after buying an additional 1,413,257 shares during the last quarter. Finally, Wellington Management Group LLP grew its position in shares of Molina Healthcare by 40.4% in the 1st quarter. Wellington Management Group LLP now owns 2,603,321 shares of the company’s stock worth $696,362,000 after buying an additional 749,696 shares during the last quarter. 98.11% of the stock is currently owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.